
|Videos|April 1, 2022
Impact of Long-Acting HIV Prevention Drugs
A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Toothpaste Tablets Are Gaining Popularity—Here’s Where Pharmacists Fit In
2
Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy
3
FDA Grants National Priority Vouchers to Enlicitide Decanoate, Sacituzumab Tirumotecan
4
Twists, Turns, and Tapers: Navigating the Benzodiazepine Ride
5












































































































































































































